Ascendis Pharma A/S (ASND) Stock Price & Growth Analysis

Quote Panel

Updated October 25, 2024

1W 1.30 % 1M -11.56 % 3M -2.56 % 1Y 46.44 %

Key Metrics

Market Cap
7.47B
Shares Outstanding
57.35M
Share in Float
56.61M
Dividende
0

Earning Date
05 Nov 2024
Price Target
130.32
Average Volume
623793
Beta
0.637

Range
86.545-161.0
Industry
Biotechnology
Website
https://ascendispharma.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

21.63x

P/S Ratio

-21.40x

P/B Ratio

-2.1

Debt/Equity

-154.2%

Net Margin

$-9.3

EPS

How ASND compares to sector?

P/E Ratio

Relative Strength

ASND

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$515M

1325%

2025-Revenue

$2.52

-31%

2025-EPS

$515M

-298%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

upgrade

Previous: Buy

2024-06-25

Now: Positive

Cowen & Co.

upgrade

Previous: Not converted

2024-06-25

Now: Buy

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-3.05
vs -1.73

Q4.22

N/A

-3.78
vs -2.14

Q1.23

N/A

-2.12
vs -2.48

Q2.23

N/A

-2.35
vs -1.54

Q3.23

N/A

-3.12
vs -3.05

Q4.23

N/A

-1.66
vs -3.78

Q1.24

N/A

-2.48
vs -2.12

Q2.24

N/A

-2.05
vs -2.35

Q3.24

N/A

-1.54
vs -3.12

Q4.24

N/A

-1.42
vs -1.66

Sales Growth

YoY

Current

Estimates

Q3.22

+1274%

15.3M vs 1.1M

Q4.22

+368%

22.9M vs 4.9M

Q1.23

+392%

33.6M vs 6.8M

Q2.23

+669%

47.4M vs 6.2M

Q3.23

+214%

48M vs 15.3M

Q4.23

+501%

137.7M vs 22.9M

Q1.24

+185%

95.9M vs 33.6M

Q2.24

-24%

36.2M vs 47.4M

Q3.24

+70%

81.8M vs 48M

Q4.24

-39%

84.5M vs 137.7M

Return on Equity

QoQ

Q3.22

-37%

-0.37
vs -0.13

Q4.22

-79%

-0.79
vs -0.37

Q1.23

-66%

-0.66
vs -0.79

Q2.23

-187%

-1.87
vs -0.66

Q3.23

+221%

2.21
vs -1.87

Q4.23

+60%

0.6
vs 2.21

Q1.24

+55%

0.55
vs 0.6

Q2.24

+34%

0.34
vs 0.55

Institutionnal Ownership

QoQ

Q3.22

197

197
vs 174

13%

Q4.22

202

202
vs 197

Q1.23

177

177
vs 202

-12%

Q2.23

173

173
vs 177

-2%

Q3.23

172

172
vs 173

-1%

Q4.23

200

200
vs 172

16%

Q1.24

203

203
vs 200

Q2.24

213

213
vs 203

Company Description

N/A

21.63x

-21.40x

-2.1

-154.2%

$-9.3

$515M

$2.52

$515M

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!